SAN MATEO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will report results for its third quarter 2008 on Thursday, November 6, 2008, after the market closes.
A conference call to review the results and discuss corporate and clinical initiatives for the remainder of 2008 and into 2009 will begin at 4:30 p.m. ET (1:30 p.m. PT) on November 6, 2008 and will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.
To participate in the conference call, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). In addition, a dial-up replay of the conference call will be available beginning November 6, 2008 at 8:00 p.m. ET (5:00 p.m. PT) and ending on November 16, 2008. The replay telephone number is 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 301804.
A live web cast of the call will also be available from the Investor Relations section on the corporate web site at http://www.neurogesx.com. A web cast replay can be accessed on the corporate web site beginning November 6, 2008 at the same time as the conference call and will remain on the site for one month ending December 6, 2008.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focu
|SOURCE NeurogesX, Inc.|
Copyright©2008 PR Newswire.
All rights reserved